Day: Day 1: 2026

Empowering Pathologists to Scale Precision Biomarker Assessment and Patient Identification in Breast Cancer Care

This session will explore the role of digital and computational pathology in enhancing precision biomarker assessment and improving patient identification in breast cancer care. Participants will review the emerging evidence supporting these technologies, discuss institutional requirements for implementation, and examine key factors influencing their scalable adoption in routine clinical practice. The discussion aims to identify […]

Understanding MET-Driven Resistance in Metastatic EGFRm NSCLC

This session will focus on enhancing diagnostic precision through various methodologies of MET alteration testing, and will explore the role of a coordinated multidisciplinary approach to help ensure completion of biomarker testing. Attendees will learn about and discuss various testing technologies and the clinical significance of MET alterations, particularly in patients exhibiting progressive disease following […]

Computational Pathology in Precision Oncology: From Innovation to Implementation

This interactive session will explore how computational pathology and AI-enabled biomarker assessment may contribute to the future of precision oncology and support more informed treatment decisions, including those involving antibody-drug conjugates. Using recent examples, including Quantitative Continuous Scoring (QCS), the session will focus on the broader implications of incorporating these approaches into patient care. Through […]

Beyond Oncology: Advances in Personalized Medicine Fueling New Approaches for Patients

While oncology has driven many of the earliest breakthroughs in precision medicine, rapid advances in genomics, biomarker science, AI, digital health, and molecular diagnostics are now transforming care across a wide range of diseases and conditions. From cardiovascular and neurodegenerative diseases to autoimmune disorders, rare disease, infectious disease, and metabolic conditions, precision medicine is reshaping […]

Practicing Responsible AI in Molecular Diagnostics: Building Trust, Quality and Clinical Value

As molecular diagnostics platforms generate increasingly large and complex datasets, AI is emerging as a powerful tool to support quality, interpretation, and clinical decision-making across disease areas, including immunology and rare disease. This panel discussion will explore how organizations across the personalized medicine ecosystem are using AI today to improve the analysis and usability of […]